AngioDynamics
ANGO
147 hedge funds and large institutions have $437M invested in AngioDynamics in 2026 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 54 increasing their positions, 57 reducing their positions, and 35 closing their positions.
206% more call options, than puts
Call options by funds: $646K | Put options by funds: $211K
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.81% less ownership
Funds ownership: 94.3% → 93.5% (-0.81%)
5% less repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 57
12% less funds holding
Funds holding: 167 → 147 (-20)
12% less capital invested
Capital invested by funds: $497M → $437M (-$60M)
46% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 35
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
+$6.09M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$3.95M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$3.86M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$3.02M |
| 5 |
RA
Royce & Associates
New York
|
+$2.83M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$4.63M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$3.67M |
| 3 |
PFC
Phocas Financial Corp
Alameda,
California
|
-$3.23M |
| 4 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
-$2.52M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$2.27M |
ANGO Hedge Fund Activity: Q1 2026 in Review
147 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q1 2026, worth a combined $437M — down 12% from $497M a quarter earlier.
Sellers outnumbered buyers: 35 funds closed out of ANGO and 19 opened new positions — a net loss of 16 holders — while 57 trimmed existing stakes and 54 added.
The largest buyer was Divisadero Street Capital Management, opening a new position worth an estimated $6.09M. The largest seller was Essex Investment Management, exiting entirely with an estimated $4.63M sold.
- 147 institutional investors held AngioDynamics (ANGO) as of Q1 2026, down from 167 in Q4 2025.
- Funds reported $437M of AngioDynamics stock for Q1 2026, down 12% quarter-over-quarter.
- 19 funds opened new AngioDynamics positions in Q1 2026 and 35 closed out, a net change of -16 holders.
- The largest AngioDynamics buyer in Q1 2026 was Divisadero Street Capital Management, an estimated $6.09M added.
- The largest AngioDynamics seller in Q1 2026 was Essex Investment Management, an estimated $4.63M sold.
Based on aggregated 13F filings for Q1 2026.